Voyager Therapeutics Reports First Quarter 2024 Financial and Operating Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- S&P 500, Nasdaq futures tick up as tech steadies, Micron earnings eyed
- Brent extends losses on expectations of smoother crude flows via Hormuz
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
Voyager Therapeutics (VYGR) PT Lowered to $8 at Wedbush
May 14, 2024 6:47 AM EDTWedbush analyst Laura Chico lowered the price target on Voyager Therapeutics (NASDAQ: VYGR) to $8.00 (from $10.00) while maintaining a Neutral rating.
The analyst comments "Remain Neutral rated on VYGR, new $8 target. On the heels of the AGCST meeting, the 1Q24 VYGR update... More
